Publication Beamlines Strategic Pillar
Okbinoglu; Tulin; Kennepohl; Pierre (2020). The Nature of S-N Bonding in Sulfonamides and Related Compounds: Insights into π-Bonding Contributions from Sulfur K-Edge XAS. Patent Number: 10.26434/chemrxiv.13204985.v1. SXRMB
Wallweber, H.; Mortara, K.; Ferri, E.; Rudolph, J.; Wang, W. et al. (2020). Structure of apo unphosphorylated IRE1. Protein Data Bank: 6w3b. CMCF-ID
Wallweber, H.; Mortara, K.; Ferri, E.; Wang, W.; Rudolph, J. et al. (2020). Structure of phosphorylated apo IRE1. Protein Data Bank: 6w3c. CMCF-ID
Wang, F.; Cheng, W.; Shang, H.; Wang, R.; Zhang, B. et al. (2021). The Crystal Structure of human MTH1 from Biortus. Protein Data Bank: 7esf. CMCF-ID
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0.
(2023). Antibodies to tigit. Patent Number: IL298111A.
(2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2.
(2023). teclistamab. Patent Number: NL301219I2.
(2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1.
(2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T.